Citation Impact
Citing Papers
Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
2006
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout
Bosentan Therapy in Patients With Eisenmenger Syndrome
2006
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Identifying women with severe angiographic coronary disease
2009
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 Standout
Continuous haemodynamic monitoring during exercise in patients with pulmonary hypertension
2004
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
EAE/ASE Recommendations for the Use of Echocardiography in New Transcatheter Interventions for Valvular Heart Disease
2011
Dietary calcium intake and risk of cardiovascular disease, stroke, and fracture in a population with low calcium intake
2017
Osteoporosis
2019 Standout
Primary Pulmonary Hypertension
2000
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Coronary microvascular dysfunction in the clinical setting: from mystery to reality
2012
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: Results of the BREATHE-5 open-label extension study
2007
Pathology of Drug-Eluting Stents in Humans
2006 Standout
Pediatric Pulmonary Hypertension
2013
Surgical Treatments/Interventions for Pulmonary Arterial Hypertension
2004
Antithrombotic Therapy for VTE Disease
2016 Standout
Rare diseases bullet 5: Primary pulmonary hypertension
1999
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 Standout
Drug-eluting stent thrombosis
2005
Lung Transplantation in Sarcoidosis
2007
Clinical classification of pulmonary hypertension
2004 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Janus face of vascular endothelial growth factor: The obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension
2002
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger???s Syndrome
2008
Angiogenesis in health and disease
2003 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Radiation safety program for the cardiac catheterization laboratory
2011
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Sarcoidosis
2013 Standout
The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation
2016
Coronary stents: A materials perspective
2006
Antithrombotic Therapy for VTE Disease
2012 Standout
Pulmonary hypertension in sickle cell hemoglobinopathy: A clinicopathologic study of 20 cases
2002
Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR)
2008
Reconstructing sickle cell disease: A data‐based analysis of the “hyperhemolysis paradigm” for pulmonary hypertension from the perspective of evidence‐based medicine
2010
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Down patients with Eisenmenger syndrome: Is bosentan treatment an option?
2008
Mutation of von Hippel–Lindau Tumour Suppressor and Human Cardiopulmonary Physiology
2006 StandoutNobel
Upregulation of endothelial nitric oxide synthase and endothelin‐1 in pulmonary hypertension secondary to heart failure in aorta‐banded rats
2004
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Sickle-cell disease
2010 Standout
Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs
2002
Characteristics and Outcomes of Patients With Sarcoidosis Listed for Lung Transplantation
2001
A Randomized Trial to Assess Catheter Ablation Versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart Failure
2013
Secondary prevention with folic acid: effects on clinical outcomes
2003
Transcatheter aortic valve implantation: 10-year anniversary. Part II: clinical implications
2012
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
2002 Standout
Clinical and Angiographic Outcome After Implantation of Drug-Eluting Stents in Bifurcation Lesions With the Crush Stent Technique
2005
Pulmonary Arterial Hypertension
2004
On the mechanisms of biocompatibility
2008 Standout
Standardized End Point Definitions for Coronary Intervention Trials
2018
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Mechanisms of disease: pulmonary arterial hypertension
2011
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Sarcoidosis
2007 Standout
Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery
2002
Lung transplantation for pulmonary vascular disease
2002
Systemic Vascular Load in Calcific Degenerative Aortic Valve Stenosis
2015
Introduction
2004
Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension
1999
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation
2016
Predicting Mortality in Patients With Sarcoidosis Awaiting Lung Transplantation
2003
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
2005 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery
2007
Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis
2006
Endothelial Nitric Oxide Synthase in Vascular Disease
2006 Standout
Pulmonary Vascular Disease in Adults With Congenital Heart Disease
2007
Pulmonary Arterial Hypertension
2006
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
2006 Standout
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
2018
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Clinical End Points in Coronary Stent Trials
2007 Standout
Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension
2004
Drug-Eluting Stent and Coronary Thrombosis
2007
Pathobiology of Pulmonary Hypertension
2007
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Ghada Mikhail being referenced
High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension
1998
Delayed mortality from aortic dissection post transcatheter aortic valve implantation (TAVI): The tip of the iceberg
2010
Recognising bicuspid aortic stenosis in patients referred for transcatheter aortic valve implantation: routine screening with three-dimensional transoesophageal echocardiography
2010
Myocardial ischemia in aortic stenosis: Insights from arterial pulse-wave dynamics after percutaneous aortic valve replacement
2013
SCAI Consensus Document on Occupational Radiation Exposure to the Pregnant Cardiologist and Technical Personnel
2011
Safety and tolerability of bosentan in adults with Eisenmenger physiology
2004
SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel
2010
Medium term results of lung transplantation for end stage pulmonary sarcoidosis
1998
Long-term results of heart-lung transplantation for pulmonary hypertension
1997
An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension
1997
Coronary revascularisation in women
2006
Why Does Primary Angioplasty Not Work in Registries? Quantifying the Susceptibility of Real-World Comparative Effectiveness Data to Allocation Bias
2012
Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects
2004
Arterial Pulse Wave Dynamics After Percutaneous Aortic Valve Replacement
2011
Intraprocedural Stent Thrombosis During Implantation of Sirolimus-Eluting Stents
2004
Gender differences in coronary heart disease
2016